SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
clinical 2,564 words KG: A Multicenter, Phase III, Randomized, Double Blind, Placebo-Controlled Study ... (NCT05143528)
Contents

A Multicenter, Phase III, Randomized, Double Blind, Placebo-Controlled Study ... (NCT05143528)

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (38)

Stress Granule Phase Separation Modulators
Score: 0.72APOE Isoform Conversion Therapy
Score: 0.72Noradrenergic-Tau Propagation Blockade
Score: 0.71Orexin-Microglia Modulation Therapy
Score: 0.71Lysosomal Enzyme Trafficking Correction
Score: 0.71Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70Lysosomal Calcium Channel Modulation Therapy
Score: 0.70Reelin-Mediated Cytoskeletal Stabilization Protocol
Score: 0.69Lysosomal Positioning Dynamics Modulation
Score: 0.69Excitatory Neuron Vulnerability via SLC17A7 Downregulation
Score: 0.67Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66Synaptic Phosphatidylserine Masking via Annexin A1 Mimetics
Score: 0.62Synaptic Vesicle Tau Capture Inhibition
Score: 0.58HSP90-Tau Disaggregation Complex Enhancement
Score: 0.57Trans-Synaptic Adhesion Molecule Modulation
Score: 0.54Lysosomal Membrane Repair Enhancement
Score: 0.54
← Prevpg 2/2

Related Analyses (6)

Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archivedMicroglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archivedDigital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (3)

ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40Cytochrome Therapeutics
clinical · proposed · Score: 0.40Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.40

See Also (15)

Section 201: Advanced Mitochondrial Biogenesis and PGC-
therapeutic · Pages share 5 hypothesesNeurodegeneration
disease · Pages share 5 hypothesesA Phase 2 Double-Blind, Randomized, Placebo-Controlled
clinical · Pages share 5 hypothesesMitochondrial Replacement Therapy for Neurodegeneration
therapeutic · Pages share 5 hypothesesSection 204: Advanced Proteostasis and Protein Quality
therapeutic · Pages share 5 hypotheses

Knowledge Graph (2 edges)

A Multicenter, Phase III, Randomized, Double Blind, Placebo-Controlled Study ... (NCT05143528) references ULK1
A Multicenter, Phase III, Randomized, Double Blind, Placebo-Controlled Study ... (NCT05143528) references HDAC

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas